Klaus-Rüdiger Trott Selected Research

Klaus-Rüdiger Trott Research Topics

5	Neoplasms (Cancer) 10/2017 - 01/2004
2	Heart Diseases (Heart Disease) 11/2015 - 08/2011
2	Breast Neoplasms (Breast Cancer) 08/2011 - 01/2007
2	Prostatic Neoplasms (Prostate Cancer) 03/2005 - 01/2002
1	Pneumonia (Pneumonitis) 01/2020
1	COVID-19 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2007
1	Peptic Ulcer (Peptic Ulcers) 01/2007
1	Atherosclerosis 01/2007
1	Inflammation (Inflammations) 09/2005
1	Leukemia 03/2005
1	Seminoma 01/2004
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2004
1	Thyroid Neoplasms (Thyroid Cancer) 01/2004
1	Hodgkin Disease (Hodgkin's Disease) 01/2004
1	Melanoma (Melanoma, Malignant) 01/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2002
1	Radiation-Induced Leukemia (Leukemia, Radiation Induced) 01/2002
1	Endometrial Neoplasms (Endometrial Cancer) 01/2002

1	bunazosin (Andante)IBA 10/2017
1	Protons (Proton)IBA 10/2017
1	Biotin (Vitamin H)FDA Link 01/2014
1	StreptavidinIBA 01/2014
1	SuspensionsIBA 01/2014
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 09/2005
1	CarrageenanIBA 09/2005
1	EnzymesIBA 09/2005
1	ImmunosorbentsIBA 09/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2005
1	CytokinesIBA 09/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2005
1	Heme Oxygenase-1IBA 09/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2005
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2005
1	Indicators and Reagents (Reagents)IBA 01/2002

9	Radiotherapy 01/2020 - 01/2002
2	Therapeutics 10/2017 - 01/2004
1	Proton Therapy 10/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2005
1	Conformal Radiotherapy 01/2002